Efficacy of trovafloxacin for treatment of experimental Bacteroides infection in young and senescent mice.

Podobne zapisy

• In vivo efficacy of trovafloxacin (CP-99,217), a new quinolone, in experimental intra-abdominal abscesses caused by Bacteroides fragilis and Escherichia coli.
  od: Thadepalli, H, i wsp.
  Wydane: (1997)
• In vivo effects of rufloxacin and ciprofloxacin on T-cell subsets and tumor necrosis factor production in mice infected with Bacteroides fragilis.
  od: Gollapudi, S V, i wsp.
  Wydane: (1993)
• Therapeutic evaluation of difloxacin (A-56619) and A-56620 for experimentally induced Bacteroides fragilis-associated intra-abdominal abscess.
  od: Thadepalli, H, i wsp.
  Wydane: (1986)
• Use of lymphokines in treatment of experimental intra-abdominal abscess caused by Bacteroides fragilis.
  od: Gollapudi, S V, i wsp.
  Wydane: (1988)
• Efficacy of Trovafloxacin against Experimental Staphylococcus aureus Endocarditis
  od: Kaatz, Glenn W., i wsp.
  Wydane: (1998)